Overview
Cencora PharmaLex supports pharmaceutical, biotechnology and medical-technology companies across development, authorization and lifecycle management. Its portfolio covers regulatory strategy and operations, CMC, quality management, pharmacovigilance, epidemiology, market access and specialized scientific services. BlueReg merged into PharmaLex in November 2022. PharmaLex now operates under the Cencora PharmaLex brand while services and insights transition to cencora.com.